MedTrace Logo

Human Microbiome Research and Development for Overcoming Pediatric Diseases

NCT06812091 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-02-06

No results posted yet for this study

Summary

Prediction and treatment of pediatric diseases and long-term outcomes through microbiome and multi-omics analysis by life cycle: We aim to demonstrate that a wide range of diseases are associated with gut microbiome dysbiosis and to investigate the subsequent recovery (restoration) or further deterioration of the gut microbiome over time. This study seeks to offer a novel perspective on changes in the gut microbiome, particularly in the context of the gut-lung and gut-brain axes.

Conditions

  • Human Microbiome
  • Pediatrics
  • Disease
  • Growth & Development

Sponsors & Collaborators

  • Hanyang University

    lead OTHER

Principal Investigators

  • Hyun-Kyung Park, MD · Hanyang University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2026-01-01
Completion
2030-01-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06812091 on ClinicalTrials.gov